Drug intelligence / Profile preview

CAN-1

Development stage
Unknown
Lead developer
Medalchemy
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01

Overview

**CAN-1** is an official Spanish registry identifier for one of the first standardized medicinal cannabis preparations registered by Curaleaf with the Spanish Agency of Medicines and Medical Devices. Curaleaf disclosed that CAN-1 and CAN-2 correspond to two distinct preparations, one THC-dominant and one CBD-dominant, but did not publicly assign the cannabinoid composition specifically to CAN-1. The preparation is intended for supply to hospital pharmacies for preparation of patient-specific magistral cannabis formulas under Spain's medicinal-cannabis framework. ([ir.curaleaf.com](https://ir.curaleaf.com/2026-07-13-Curaleaf-First-to-Secure-Registration-for-Standardized-Cannabis-Preparations-in-Spain))

Other names
CAN-1CAN1CAN 1

Beyond the preview

Go deeper on CAN-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAN-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call